{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:45:50Z","timestamp":1761864350232,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.transproceed.2021.09.013","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T09:07:18Z","timestamp":1634288838000},"page":"2655-2658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protocol for Optimizing the Use of Kidneys From Donors With Seropositivity for Hepatitis C Virus in Seronegative Recipients"],"prefix":"10.1016","volume":"53","author":[{"given":"Antonio","family":"Franco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Moreso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuncion","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuria","family":"Esforzado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Llorente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Guirado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Melilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco Gonzalez","family":"Roncero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2021.09.013_bib0001","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM199108153250702","article-title":"Transmission of hepatitis C virus by organ transplantation","volume":"325","author":"Pereira","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0002","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1097\/TP.0000000000002323","article-title":"Changes in utilization and discard of HCV antibody-positive deceased donor kidneys in the era of direct-acting antiviral therapy","volume":"102","author":"Bowring","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0003","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/ajt.14381","article-title":"The American Society of Transplantation consensus conference on the use of hepatitis C viremic donors in solid organ transplantation","volume":"17","author":"Levitsky","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0004","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1056\/NEJMoa1702417","article-title":"Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection","volume":"378","author":"Zeuzem","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0005","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/tri.13410","article-title":"Renal transplantation from seropositive hepatitis C virus donors to seronegative recipients in Spain: a prospective study","volume":"32","author":"Franco","year":"2019","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0006","doi-asserted-by":"crossref","first-page":"e13598","DOI":"10.1111\/ctr.13598","article-title":"Use of HCV Ab+\/NAT\u2212 donors in HCV na\u00efve renal transplant recipients to expand the kidney donor pool","volume":"33","author":"Dao","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0007","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1111\/ajt.15031","article-title":"Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia","volume":"18","author":"de Vera","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ekir.2016.09.058","article-title":"Transplantation of renal allografts from organ donors reactive for HCV antibodies to HCV-negative recipients: safety and clinical outcome","volume":"2","author":"Nowak","year":"2016","journal-title":"Kidney Int Reports"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0009","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1600-6143.2011.03460.x","article-title":"Risk of window period hepatitis-C infection in high infectious risk donors: systematic review and meta-analysis","volume":"11","author":"Kucirka","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0010","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1111\/ajt.13283","article-title":"Transmission of hepatitis C virus from organ donors despite nucleic acid test screening","volume":"15","author":"Suryaprasad","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0011","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3748\/wjg.v6.i6.805","article-title":"Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C","volume":"6","author":"Yan","year":"2000","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0012","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients an open-label nonrandomized trial","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0013","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C\u2013infected kidneys into uninfected recipients: a single-group trial","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0014","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C\u2013infected donors to hepatitis C\u2013negative recipients: single center experience","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0015","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.31011","article-title":"Hepatitis C virus NAT-positive solid organ allografts transplanted into hepatitis C virus\u2013negative recipients: a real-world experience","volume":"72","author":"Kapila","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0016","doi-asserted-by":"crossref","first-page":"e13146","DOI":"10.1111\/tid.13146","article-title":"Successful early sofosbuvir-based antiviral treatment after transplantation of kidneys from HCV-viremic donors into HCV-negative recipients","volume":"21","author":"Friebus-Kardash","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0017","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/ajt.15664","article-title":"Ultra-short duration direct acting antiviral prophylaxis to prevent virus transmission from hepatitis C viremic donors to hepatitis C negative kidney transplant recipients","volume":"20","author":"Gupta","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2021.09.013_bib0018","doi-asserted-by":"crossref","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521006898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134521006898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:39:31Z","timestamp":1758577171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134521006898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0041134521006898"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.09.013","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol for Optimizing the Use of Kidneys From Donors With Seropositivity for Hepatitis C Virus in Seronegative Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2021.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}